Spain has solidified its position as a powerhouse for clinical research within the European Union. Backed by a highly integrated national health system, a digitized network of hospitals, and swift regulatory turnaround times under the EU Clinical Trials Regulation (CTR), it has become a magnet for global biopharmaceutical investment.
However, entering or scaling operations within this...